Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anthony Arveschoug

Orthopaedic Surgery Taylor, MI Medical Doctor

NPI 1740770270 CMS profile 4358640

10000 Telegraph Rd Ste 100, Taylor, MI 48180

Open in the dashboard

General payments

$9,841

83 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anthony Arveschoug of Taylor, MI is reported in the CMS Open Payments database as having received $9,841 across 83 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $426 12
2024 General $903 16
2023 General $1,811 10
2022 General $2,621 18
2021 General $2,004 13
2020 General $189 2
2019 General $1,887 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anthony Arveschoug
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Anthony Arveschoug were reported at $426. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Anthony Arveschoug Orthopaedic Surgery median Middle half National median
2019 $1,887 $644 $140–$2,844 $163
2020 $189 $312 $75–$1,860 $114
2021 $2,004 $520 $117–$2,495 $132
2022 $2,621 $598 $128–$2,731 $149
2023 $1,811 $461 $128–$2,264 $160
2024 $903 $497 $134–$2,475 $164
2025 $426 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pinnacle, Inc $3,949 10 payments
  2. Stryker Corporation $1,754 25 payments
  3. Synthes GmbH $974 2 payments
  4. Zimmer Biomet Holdings, Inc. $485 4 payments
  5. SI-BONE, Inc. $471 6 payments
  6. Globus Medical, Inc. $411 5 payments
  7. DePuy Synthes Sales Inc. $370 7 payments
  8. Medtronic, Inc. $287 6 payments
  9. OrthoPediatrics Corp. $153 1 payment
  10. AxoGen $147 1 payment
  11. Other $841 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,971 75 payments
  2. Education $3,742 5 payments
  3. Travel and Lodging $974 2 payments
  4. Consulting Fee $153 1 payment
Products named General payments · program years 2019–2025
  1. MAKO $655 6 payments
  2. ACCOLADE $607 13 payments
  3. Xvision $591 5 payments
  4. TRIATHLON $323 11 payments
  5. TRITANIUM $309 2 payments
  6. CASCADIA INTERBODY SYSTEM $186 2 payments
  7. RESTORATION $177 10 payments
  8. TRIDENT $177 10 payments
  9. CLYDESDALE PTC SPINAL SYSTEM $172 1 payment
  10. GMRS $171 7 payments
  11. Other $3,902 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

187

Median for Orthopedic Surgery: 203

Drug cost

$1,472

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pregabalin Generic 11 $395
Methylprednisolone Generic 59 $382
Methocarbamol Generic 19 $276
Gabapentin Generic 29 $215
Tramadol Hcl Generic 26 $104
Cyclobenzaprine Hcl Generic 24 $64
Meloxicam Generic 19 $34

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$15,218

Medicare's payments for the services billed

Medicare patients

78

Average age 73

Services billed

382

41 women, 37 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 41%
Ischemic heart disease 37%
Chronic kidney disease 37%
Heart failure 26%
Depression 23%
Atrial fibrillation 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

83 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record